Wednesday, April 8, 2026
32.2 C
Bengaluru

Brecht Vanneste has been appointed as Managing Director of MSD India

He steps into the role with a clear mandate to lead the Human Health business in India, drawing on the strong momentum and commitment of teams across Mumbai and the wider country. His leadership will focus on advancing the organization’s next phase of growth while strengthening its impact on patient outcomes at scale.

With India being one of the world’s most significant healthcare markets, he will be working closely with teams to drive innovation, collaboration, and meaningful healthcare access across the country.

MedicinMan wishes him success in this new role.

Hot this week

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie

A Tale of Two Truths: Severance, Up in the...

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Topics

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...
spot_img

Related Articles

spot_imgspot_img